• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LNDC

LNDC

Landec Corporation

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD8.76

-0.32 (-3.52%)

Company Profile

CEO

Albert Bolles

IPO Date

1996-02-16

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$9.01

Prev. Close

$9.08

Day Low

$8.75

Day High

$9.01

52W Low

$7.65

52W High

$12.04

Market Cap

$0.26B

Volume

0.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.8%

Avg Negative

12.2%

Avg Neutral

57.0%

News Feed

Landec Corporation (LNDC) CEO Albert Bolles on Q4 2021 Results - Earnings Call Transcript

Seeking Alpha·7/28/2021·↓ negative

Landec (LNDC) Q4 Earnings and Revenues Surpass Estimates

Zacks Investment Research·7/28/2021·↑ positive

Landec: Q4 Earnings Insights

Benzinga·7/28/2021·↑ positive

Landec Corporation Sets Fourth Quarter 2021 Earnings Conference Call for July 28, 2021 at 2 p.m. PT

GlobeNewsWire·7/14/2021·↓ negative

Landec Sells Investment in Windset Holdings

GlobeNewsWire·6/1/2021·↑ positive

Landec Enters into Transportation Management, Warehousing, and Transportation Services Agreement with Castellini Company LLC

GlobeNewsWire·5/5/2021·↑ positive

Landec (LNDC) Surges 7.1%: Is This an Indication of Further Gains?

Zacks Investment Research·4/16/2021·↑ positive

Landec Corporation's (LNDC) CEO Dr. Albert Bolles on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·4/8/2021·↓ negative

Landec (LNDC) Reports Q3 Loss, Lags Revenue Estimates

Zacks Investment Research·4/7/2021·↑ positive

Landec: Q3 Earnings Insights

Benzinga·4/7/2021·↓ negative